| ◆英語タイトル：Global Drug Eluting Balloons (DEB) Market Research Report 2023
|
 | ◆商品コード：QYR23MA7824
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月（※2025年版があります。お問い合わせください。）
◆ページ数：91
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
|
◆販売価格オプション
（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
薬剤溶出バルーン（DEB：Drug Eluting Balloons）は、特に血管内治療において重要な役割を果たしている医療機器の一つです。主に、動脈硬化症や再狭窄を防ぐために使用されるこのデバイスは、バルーンの表面に薬剤を含有させ、血管の内腔を拡張しつつ、その薬剤を直接血管壁に導入することができます。DEBは、従来のバルーンにはない特有の利点を持ち、さまざまな疾患治療において利用されています。
DEBの定義は、薬剤がバルーンの表面にコーティングされており、バルーンが拡張する際にその薬剤が血管壁に放出される装置を指します。この薬剤は、主に抗プロリフェラティブ薬や抗炎症薬であり、血管内の細胞の増殖を抑制したり、再狭窄を防ぐ目的で使用されます。DEBは、特に下肢動脈の治療や冠動脈の治療で幅広く用いられています。
DEBの特徴としては、まずその薬剤放出メカニズムが挙げられます。バルーンを膨らませることで、一時的に圧力がかかり、薬剤が血管壁に浸透しやすくなります。これによって薬剤の局所濃度が高まり、効果的な治療が可能となります。また、DEBは金属製のステントを伴わないため、ステントのような長期的な構造物が血管内に残らないという利点があります。このため、患者にとっての合併症リスクが減少し、血管の自然な機能が保持される可能性が高まります。
DEBの種類には、使用される薬剤や用量、バルーンの材質やサイズなどによっていくつかのバリエーションがあります。例として、Paclitaxel（パクリタキセル）を用いたDEBが広く使用されています。この薬剤は、細胞の増殖を抑える効果があり、特に再狭窄防止に優れています。また、Sirolimus（シロリムス）を使用したDEBもあり、こちらは主に血管内での炎症反応を抑制する作用があります。バルーンのサイズや直径は、治療する血管の状態や位置に応じて選択されます。
DEBはその用途において非常に多岐にわたりますが、特に末梢動脈疾患や冠動脈疾患においてその効果を発揮しています。末梢動脈疾患におけるDEB治療は、下肢の動脈に血流が障害されることによる痛みや潰瘍を改善するために用いられます。これにより患者の生活の質が向上することが期待されます。冠動脈疾患においては、狭心症や心筋梗塞の予防・治療として用いられ、特に再狭窄のリスクが高い患者にとっては有効な治療オプションとなります。
関連技術としては、DEBに加えて、バイオデグレーダブルステント（生分解性ステント）や薬剤溶出ステント（DES：Drug Eluting Stent）などがあります。これらは、血管の再狭窄を防ぐために薬剤を放出する機能を持っている点で共通していますが、根本的な構造や使用方法は異なります。薬剤溶出ステントは、金属またはポリマーで構成されており、血管内に長期間留まります。一方、DEBは一時的に使用され、使用後は体内に残らないため、長期的な血管の健康に寄与することが期待されます。
だが、DEBにはいくつかの制限や課題も存在します。例えば、薬剤の浸透効果は血管の状態や薬剤の特性によって異なるため、すべての患者において同様の効果が得られるわけではありません。また、比較的新しい技術であるため、その長期的な効果や安全性については、さらなる研究が必要とされています。加えて、デバイス自体のコストやアクセスの難しさも、臨床現場での普及にあたっての障壁となることがあります。
DEBは、今後の医療技術の進歩に寄与する可能性を秘めています。特に、個別化医療や再生医療の進展に伴い、DEBに使用する薬剤やバルーンの材料も新しい技術が導入され、より効果的で安全な治療法が開発されることが期待されています。加えて、臨床データの蓄積が進むことで、DEBの適応症や治療戦略も改変され、患者にとってのメリットがさらに高まると考えられています。
薬剤溶出バルーンは、血管内治療において非常に重要な医療器具であり、今後の医療現場における中心的な役割を担っていくことでしょう。患者の生活の質を向上させる新しい治療法として、今後の発展が非常に楽しみです。 |
本調査レポートは世界の薬剤溶出バルーン（DEB）市場について調査・分析し、世界の薬剤溶出バルーン（DEB）市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（末梢DEB、冠動脈DEB）、用途別セグメント分析（カテーテル検査室、病院、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、B. Braun、Medtronic、Boston Scientific、BD、Yinyi、Philips、Eurocor、Aachen Resonance、Biotronicなどが含まれています。世界の薬剤溶出バルーン（DEB）市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、薬剤溶出バルーン（DEB）市場規模を推定する際に考慮しました。
・薬剤溶出バルーン（DEB）市場の概要
- 製品の定義
- 薬剤溶出バルーン（DEB）のタイプ別セグメント
- 世界の薬剤溶出バルーン（DEB）市場規模：タイプ別分析（末梢DEB、冠動脈DEB）
- 薬剤溶出バルーン（DEB）の用途別セグメント
- 世界の薬剤溶出バルーン（DEB）市場規模：用途別分析（カテーテル検査室、病院、その他）
- 世界の薬剤溶出バルーン（DEB）市場規模予測（2018年-2029年）
- 薬剤溶出バルーン（DEB）の平均価格推移（2018年-2029年）
- 前提条件と制限事項
・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 薬剤溶出バルーン（DEB）市場の競争状況およびトレンド
・薬剤溶出バルーン（DEB）の地域別市場規模
- 北米の薬剤溶出バルーン（DEB）市場規模（2018年-2029年）
- アメリカの薬剤溶出バルーン（DEB）市場規模（2018年-2029年）
- ヨーロッパの薬剤溶出バルーン（DEB）市場規模（2018年-2029年）
- アジア太平洋の薬剤溶出バルーン（DEB）市場規模（2018年-2029年）
- 中国の薬剤溶出バルーン（DEB）市場規模（2018年-2029年）
- 日本の薬剤溶出バルーン（DEB）市場規模（2018年-2029年）
- 韓国の薬剤溶出バルーン（DEB）市場規模（2018年-2029年）
- インドの薬剤溶出バルーン（DEB）市場規模（2018年-2029年）
- オーストラリアの薬剤溶出バルーン（DEB）市場規模（2018年-2029年）
- 中南米の薬剤溶出バルーン（DEB）市場規模（2018年-2029年）
- 中東・アフリカの薬剤溶出バルーン（DEB）市場規模（2018年-2029年）
・タイプ別セグメント：末梢DEB、冠動脈DEB
- 世界の薬剤溶出バルーン（DEB）のタイプ別販売量（2018年-2023年）
- 世界の薬剤溶出バルーン（DEB）のタイプ別売上（2018年-2023年）
- 世界の薬剤溶出バルーン（DEB）のタイプ別価格
・用途別セグメント：カテーテル検査室、病院、その他
- 世界の薬剤溶出バルーン（DEB）の用途別販売量（2018年-2023年）
- 世界の薬剤溶出バルーン（DEB）の用途別売上（2018年-2023年）
- 世界の薬剤溶出バルーン（DEB）の用途別価格
・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
B. Braun、Medtronic、Boston Scientific、BD、Yinyi、Philips、Eurocor、Aachen Resonance、Biotronic
・産業チェーンと販売チャネルの分析
- 薬剤溶出バルーン（DEB）産業チェーン分析
- 薬剤溶出バルーン（DEB）の主要原材料
- 薬剤溶出バルーン（DEB）の販売チャネル
- 薬剤溶出バルーン（DEB）のディストリビューター
- 薬剤溶出バルーン（DEB）の主要顧客
・薬剤溶出バルーン（DEB）市場ダイナミクス
- 薬剤溶出バルーン（DEB）の業界動向
- 薬剤溶出バルーン（DEB）市場の成長ドライバ、課題、阻害要因
・調査成果および結論
・調査方法とデータソース |
A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells.
Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure.
Highlights
The global Drug Eluting Balloons (DEB) market was valued at US$ 584 million in 2022 and is anticipated to reach US$ 1396.1 million by 2029, witnessing a CAGR of 13.1% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global Drug Eluting Balloons（DEB） key players include B. Braun, Medtronic, Boston Scientific, BD, Yinyi, etc. Global top 5 manufacturers hold a share over 84%.
Europe is the largest market, with a share about 42%, followed by North America, and Asia-Pacific, both have a share about 52 percent.
In terms of product, Peripheral DEBs is the largest segment, with a share over 57%. And in terms of application, the largest application is Hospital, followed by Catheterization Laboratory, Others.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Balloons (DEB), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Balloons (DEB).
The Drug Eluting Balloons (DEB) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug Eluting Balloons (DEB) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Balloons (DEB) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
B. Braun
Medtronic
Boston Scientific
BD
Yinyi
Philips
Eurocor
Aachen Resonance
Biotronic
Segment by Type
Peripheral DEBs
Coronary DEBs
Segment by Application
Catheterization Laboratory
Hospital
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Balloons (DEB) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Balloons (DEB) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drug Eluting Balloons (DEB) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Eluting Balloons (DEB) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Drug Eluting Balloons (DEB) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drug Eluting Balloons (DEB) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Eluting Balloons (DEB).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Balloons (DEB) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Balloons (DEB) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
1 Drug Eluting Balloons (DEB) Market Overview
1.1 Product Overview and Scope of Drug Eluting Balloons (DEB)
1.2 Drug Eluting Balloons (DEB) Segment by Type
1.2.1 Global Drug Eluting Balloons (DEB) Market Value Comparison by Type (2023-2029)
1.2.2 Peripheral DEBs
1.2.3 Coronary DEBs
1.3 Drug Eluting Balloons (DEB) Segment by Application
1.3.1 Global Drug Eluting Balloons (DEB) Market Value by Application: (2023-2029)
1.3.2 Catheterization Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Global Drug Eluting Balloons (DEB) Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Balloons (DEB) Revenue 2018-2029
1.4.2 Global Drug Eluting Balloons (DEB) Sales 2018-2029
1.4.3 Global Drug Eluting Balloons (DEB) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Drug Eluting Balloons (DEB) Market Competition by Manufacturers
2.1 Global Drug Eluting Balloons (DEB) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Drug Eluting Balloons (DEB) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Drug Eluting Balloons (DEB) Average Price by Manufacturers (2018-2023)
2.4 Global Drug Eluting Balloons (DEB) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Drug Eluting Balloons (DEB), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Balloons (DEB), Product Type & Application
2.7 Drug Eluting Balloons (DEB) Market Competitive Situation and Trends
2.7.1 Drug Eluting Balloons (DEB) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug Eluting Balloons (DEB) Players Market Share by Revenue
2.7.3 Global Drug Eluting Balloons (DEB) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Eluting Balloons (DEB) Retrospective Market Scenario by Region
3.1 Global Drug Eluting Balloons (DEB) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Drug Eluting Balloons (DEB) Global Drug Eluting Balloons (DEB) Sales by Region: 2018-2029
3.2.1 Global Drug Eluting Balloons (DEB) Sales by Region: 2018-2023
3.2.2 Global Drug Eluting Balloons (DEB) Sales by Region: 2024-2029
3.3 Global Drug Eluting Balloons (DEB) Global Drug Eluting Balloons (DEB) Revenue by Region: 2018-2029
3.3.1 Global Drug Eluting Balloons (DEB) Revenue by Region: 2018-2023
3.3.2 Global Drug Eluting Balloons (DEB) Revenue by Region: 2024-2029
3.4 North America Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.4.1 North America Drug Eluting Balloons (DEB) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Drug Eluting Balloons (DEB) Sales by Country (2018-2029)
3.4.3 North America Drug Eluting Balloons (DEB) Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Balloons (DEB) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Drug Eluting Balloons (DEB) Sales by Country (2018-2029)
3.5.3 Europe Drug Eluting Balloons (DEB) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.6.1 Asia Pacific Drug Eluting Balloons (DEB) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Drug Eluting Balloons (DEB) Sales by Country (2018-2029)
3.6.3 Asia Pacific Drug Eluting Balloons (DEB) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Balloons (DEB) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Drug Eluting Balloons (DEB) Sales by Country (2018-2029)
3.7.3 Latin America Drug Eluting Balloons (DEB) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Balloons (DEB) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Drug Eluting Balloons (DEB) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Drug Eluting Balloons (DEB) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Balloons (DEB) Sales by Type (2018-2029)
4.1.1 Global Drug Eluting Balloons (DEB) Sales by Type (2018-2023)
4.1.2 Global Drug Eluting Balloons (DEB) Sales by Type (2024-2029)
4.1.3 Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2018-2029)
4.2 Global Drug Eluting Balloons (DEB) Revenue by Type (2018-2029)
4.2.1 Global Drug Eluting Balloons (DEB) Revenue by Type (2018-2023)
4.2.2 Global Drug Eluting Balloons (DEB) Revenue by Type (2024-2029)
4.2.3 Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2018-2029)
4.3 Global Drug Eluting Balloons (DEB) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Drug Eluting Balloons (DEB) Sales by Application (2018-2029)
5.1.1 Global Drug Eluting Balloons (DEB) Sales by Application (2018-2023)
5.1.2 Global Drug Eluting Balloons (DEB) Sales by Application (2024-2029)
5.1.3 Global Drug Eluting Balloons (DEB) Sales Market Share by Application (2018-2029)
5.2 Global Drug Eluting Balloons (DEB) Revenue by Application (2018-2029)
5.2.1 Global Drug Eluting Balloons (DEB) Revenue by Application (2018-2023)
5.2.2 Global Drug Eluting Balloons (DEB) Revenue by Application (2024-2029)
5.2.3 Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2018-2029)
5.3 Global Drug Eluting Balloons (DEB) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Corporation Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 B. Braun Drug Eluting Balloons (DEB) Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Medtronic Drug Eluting Balloons (DEB) Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Corporation Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boston Scientific Drug Eluting Balloons (DEB) Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BD Drug Eluting Balloons (DEB) Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Yinyi
6.5.1 Yinyi Corporation Information
6.5.2 Yinyi Description and Business Overview
6.5.3 Yinyi Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Yinyi Drug Eluting Balloons (DEB) Product Portfolio
6.5.5 Yinyi Recent Developments/Updates
6.6 Philips
6.6.1 Philips Corporation Information
6.6.2 Philips Description and Business Overview
6.6.3 Philips Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Philips Drug Eluting Balloons (DEB) Product Portfolio
6.6.5 Philips Recent Developments/Updates
6.7 Eurocor
6.6.1 Eurocor Corporation Information
6.6.2 Eurocor Description and Business Overview
6.6.3 Eurocor Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Eurocor Drug Eluting Balloons (DEB) Product Portfolio
6.7.5 Eurocor Recent Developments/Updates
6.8 Aachen Resonance
6.8.1 Aachen Resonance Corporation Information
6.8.2 Aachen Resonance Description and Business Overview
6.8.3 Aachen Resonance Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Aachen Resonance Drug Eluting Balloons (DEB) Product Portfolio
6.8.5 Aachen Resonance Recent Developments/Updates
6.9 Biotronic
6.9.1 Biotronic Corporation Information
6.9.2 Biotronic Description and Business Overview
6.9.3 Biotronic Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Biotronic Drug Eluting Balloons (DEB) Product Portfolio
6.9.5 Biotronic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Balloons (DEB) Industry Chain Analysis
7.2 Drug Eluting Balloons (DEB) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Balloons (DEB) Production Mode & Process
7.4 Drug Eluting Balloons (DEB) Sales and Marketing
7.4.1 Drug Eluting Balloons (DEB) Sales Channels
7.4.2 Drug Eluting Balloons (DEB) Distributors
7.5 Drug Eluting Balloons (DEB) Customers
8 Drug Eluting Balloons (DEB) Market Dynamics
8.1 Drug Eluting Balloons (DEB) Industry Trends
8.2 Drug Eluting Balloons (DEB) Market Drivers
8.3 Drug Eluting Balloons (DEB) Market Challenges
8.4 Drug Eluting Balloons (DEB) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
❖ 免責事項 ❖http://www.globalresearch.jp/disclaimer